Bioartificial Kidney
End-Stage Renal Disease (ESRD)
Pre-clinicalActive
Key Facts
About IVIVA Medical
IVIVA Medical, a San Diego-based tissue engineering company founded in 2018 and now a United Therapeutics subsidiary, is pioneering the development of implantable bioartificial kidneys. The company's core technology platform utilizes advanced 3D printing to fabricate complex, layered vascular scaffolds that are seeded with cells to create functional renal tissue. This approach aims to provide a permanent, curative solution for ESRD patients, potentially eliminating the need for dialysis and overcoming the severe shortage of donor kidneys. The program is in the pre-clinical research and development stage, representing a high-risk, high-reward frontier in regenerative medicine.
View full company profileTherapeutic Areas
Other End-Stage Renal Disease (ESRD) Drugs
| Drug | Company | Phase |
|---|---|---|
| SURDIAL™ DX Hemodialysis System | Nipro Medical | Commercial |
| Bioengineered Kidney Tissue Implant | Trestle Biotherapeutics | Pre-clinical |
| SCD-Adult | SeaStar Medical | Investigational |